Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze HPCRF stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate HPCRF investment potential.

What is HPCRF stock price today?

Get real-time HPCRF stock price, historical data, and price charts on Financhill. Track HPCRF performance with our advanced analysis tools.

Is HPCRF a good investment?

Evaluate HPCRF investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy HPCRF stock?

To buy HPCRF stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of HPCRF?

View detailed market capitalization data and company valuation metrics for HPCRF on our comprehensive analysis page.

What is the P/E ratio of HPCRF?

Use our fundamental analysis tools to view HPCRF P/E ratio and compare valuation metrics with industry peers.

What are HPCRF earnings?

View HPCRF earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Home Product Center Public Co., Ltd. 10K Form

Buy

HPCRF
Home Product Center Public Co., Ltd.

Last Price:

$0.20

Seasonality Move:

1.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HPCRF News And Ratings

See the #1 stock for the next 7 days that we like better than HPCRF

HPCRF Financial Statistics

Sales & Book Value

Annual Sales:	$2B
Cash Flow:	$53.4M
Price / Cash Flow:	14.03
Annual Sales:	$0.06
Price / Book:	3.4

Profitability

EPS (TTM):	0.01400
Net Income (TTM):	$183.7M
Gross Margin:	$460.7M
Return on Equity:	23.27%
Return on Assets:	9.03%

Home Product Center Public Co., Ltd. Earnings Forecast

Key Home Product Center Public Co., Ltd. Financial Ratios

The Gross Profit Margin over the past 25 years for HPCRF is 23.29%.
The Selling, General & Administrative Expenses for HPCRF have been equal to 19.11% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Interest Expense is 10.57% of Operating Income.
The Net Earning history of HPCRF is 9.32% of Total Revenues.
Per Share Earnings over the last 25 years have been positive in 18 years.

Home Product Center Public Co., Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	OTCM
Industry:	Specialty Retail
Sector:	Consumer Discretionary
Current Symbol:	HPCRF
Website:	homepro.co.th

Debt

Debt-to-Equity Ratio:	1
Current Ratio:	0.73
Quick Ratio:	0.1

Price-to-Earnings

Trailing P/E Ratio:	14.14
Forward P/E Ratio:	0

HPCRF Technical Analysis vs Fundamental Analysis

Buy

Home Product Center Public Co., Ltd. (HPCRF) is a Buy

Is Home Product Center Public Co., Ltd. a Buy or a Sell?

Home Product Center Public Co., Ltd. stock is rated a Buy

The current Home Product Center Public Co., Ltd. [HPCRF] share price is $0.20. The Score for HPCRF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.